Financing Pharmaceutical Innovation: When Should Poor Countries Contribute?
Download full text from publisher
More about this item
KeywordsPharmaceutical pricing; Ramsey pricing; TRIPS;
- D6 - Microeconomics - - Welfare Economics
- H2 - Public Economics - - Taxation, Subsidies, and Revenue
- I1 - Health, Education, and Welfare - - Health
- O1 - Economic Development, Innovation, Technological Change, and Growth - - Economic Development
StatisticsAccess and download statistics
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:geo:guwopa:gueconwpa~03-03-15. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Marcia Suss). General contact details of provider: http://econ.georgetown.edu/ .
We have no references for this item. You can help adding them by using this form .